Effects of MDMA on attention to positive social cues and pleasantness of affective touch.
Bershad, A. K., Mayo, L. M., Van Hedger, K., McGlone, F., Walker, S. C., & de Wit, H. | Neuropsychopharmacology | 30 April 2019
Effective connectivity changes in LSD-induced altered states of consciousness in humans
Preller, K. H., Razi, A., Zeidman, P., Stämpfli, P., Friston, K. J., & Vollenweider, F. X. | Proceedings of the National Academy of Sciences | 12 February 2019
Long-lasting analgesic effect of the psychedelic drug changa: A case report
Ona, G., & Troncoso, S. | Journal of Psychedelic Studies |12 February 2019
Ayahuasca and Public Health: Health Status, Psychosocial Well-Being, Lifestyle, and Coping Strategies in a Large Sample of Ritual Ayahuasca Users
Ona, G., Kohek, M., Massaguer, T., Gomariz, A., Jiménez, D. F., Dos Santos, R. G., & Bouso, J. C. | Journal of psychoactive drugs | 7 February 2019
Greater empathy in MDMA users
Carlyle, M., Stevens, T., Fawaz, L., Marsh, B., Kosmider, S., & Morgan, C. J. | Journal of Psychopharmacology | 5 February 2019
Metabolite Profiling of Antiaddictive Alkaloids from Four Mexican Tabernaemontana Species and the Entheogenic African Shrub Tabernanthe iboga (Apocynaceae)
Krengel, F., Chevalier, Q., Dickinson, J., Santoyo, J. H., & Reyes-Chilpa, R. | Chemistry & biodiversity | 7 January 2019
The effects of ketamine on suicidality across various formulations and study settings
Dadiomov, D., & Lee, K. | Mental Health Clinician | 4 January 2019
How do psychedelics work?
Carhart-Harris, R. L. | Current opinion in psychiatry | 1 January 2019
Role of serotonin transporter and receptor gene variations in the acute effects of MDMA in healthy subjects
Vizeli, P., Meyer zu Schwabedissen, H. E., & Liechti, M. E. | ACS chemical neuroscience | 27 December 2018
DARK Classics in Chemical Neuroscience: Atropine, Scopolamine, and Other Anticholinergic Deliriant Hallucinogens
Lakstygal, A., Kolesnikova, T., Khatsko, S., Zabegalov, K., Volgin, A., Demin, K., & Kalueff, A. | ACS chemical neuroscience | 19 December 2018
Psychiatry might need some psychedelic therapy
Johnson, M. W. | International Review of Psychiatry | 3 December 2018
Monoamine biosynthesis via a noncanonical calcium-activatable aromatic amino acid decarboxylase in psilocybin mushroom
Torrens-Spence, M. P., Liu, C. T., Pluskal, T., Chung, Y. K., & Weng, J. K. | ACS chemical biology | 28 November 2018
Self-Experiments with Psychoactive Substances: A Historical Perspective
Passie, T., & Brandt, S. D. | Handbook of Experimental Pharmacology | 27 November 2018
Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions
Garcia-Romeu, A., & Richards, W. A. | International Review of Psychiatry | 13 November 2018
Neuroimaging of chronic MDMA (“ecstasy”) effects: A meta-analysis
Müller, F., Brändle, R., Liechti, M. E., & Borgwardt, S. | Neuroscience & Biobehavioral Reviews | 12 November 2018
What Psilocybin Taught Me About Dying
Back, A. L. | Journal of palliative medicine | 9 November 2018
The Varieties of the Psychedelic Experience: A Preliminary Study of the Association Between the Reported Subjective Effects and the Binding Affinity Profiles of Substituted Phenethylamines and Tryptamines
Zamberlan, F., Sanz, C., Martinez Vivot, R., Pallavicini, C., Erowid, E., & Tagliazucchi, E. | Frontiers in integrative neuroscience | 8 November 2018
Predicting Responses to Psychedelics: A Prospective Study
Haijen, E. C. H. M., Kaelen, M., Roseman, L., Timmermann, C., Russ, S., Nutt, D., ... & Carhart-Harris, R. L. | Frontiers in pharmacology | 2 November 2018
Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor
Preller, K. H., Burt, J. B., Ji, J. L., Schleifer, C. H., Adkinson, B. D., Stämpfli, P., & Vollenweider, F. X. | eLife | 25 October 2018
Psychedelic Moral Enhancement
Earp, B. D. | Royal Institute of Philosophy Supplements | 16 October 2018
Research ethics aspects of experimentation with LSD on human subjects: a historical and ethical review.
Bodnár, K. J., & Kakuk, P. | Medicine, Health Care and Philosophy | 16 October 2018
Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents.
Kivell, B., Paton, K., Kumar, N., Morani, A., Culverhouse, A., Shepherd, A., ... & Prisinzano, T. | Molecules | 11 October 2018
The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug
Jalal, B. | Psychopharmacology | 5 October 2018
Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: Contributions of the resting brain.
Müller, F., Liechti, M. E., Lang, U. E., Borgwardt, S., Wilson, M. R., Webb, A., ... & Lutz, K. | Progress in brain research | 28 September 2018
Whole-Brain Multimodal Neuroimaging Model Using Serotonin Receptor Maps Explains Non-linear Functional Effects of LSD
Deco, G., Cruzat, J., Cabral, J., Knudsen, G. M., Carhart-Harris, R. L., Whybrow, P. C., & Kringelbach, M. L. | Current biology | 27 September 2018